Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
GS-7340
DRUG
2 trials
Sponsors
Gilead Sciences
, University of North Carolina, Chapel Hill
Conditions
Chronic Hepatitis B
Healthy
Phase 1
A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B
Completed
NCT01671787
Gilead Sciences
Chronic Hepatitis B
Start: 2012-03-31
End: 2013-04-30
Updated: 2018-10-23
Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women
Completed
NCT02357602
University of North Carolina, Chapel Hill
Healthy
Start: 2015-03-31
End: 2016-11-30
Updated: 2016-11-30
Related Papers
Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues.
2017-06-01
51 citations